更新版FluoroType MTBDR V2加入IS6110分析后灵敏度提高
这项前瞻性头对头研究以1483份临床标本比较旧版与加入多拷贝IS6110序列的更新版FluoroType MTBDR,以培养和全基因组测序为参考标准。更新版总体灵敏度由70%升至87%(提高17个百分点,P=0.008),涂片阴性培养阳性标本由50%升至78%(P=0.008),两版特异性均为99%,耐药检测能力未见显著改善。
要点
- 加入IS6110后总体灵敏度由70%升至87%(P=0.008)。
- 涂片阴性培养阳性标本灵敏度由50%升至78%(P=0.008)。
- 两版特异性均为99%,耐药谱检测能力无显著提升。
核心结论
- 更新版加入IS6110靶标后显著提高MTBC检测总体灵敏度,并缩小与需反射检测流程之间的性能差距。
研究设计与样本
- 前瞻性头对头研究,纳入1483份来自肺部和肺外来源的临床标本,以培养和全基因组测序为参考标准,比较旧版与更新版FluoroType MTBDR。
主要发现
- 更新版总体灵敏度为87%,旧版为70%,提高17个百分点(P=0.008)。
- 在涂片阴性、培养阳性标本中,灵敏度由50%升至78%(P=0.008)。
- 两版特异性均为99%,保持高水平且相近。
- 由于耐药相关靶标未变,耐药谱检测能力未显著改善。
关键数值与推荐
- 总体灵敏度:更新版87%对比旧版70%(P=0.008)。
- 涂片阴性培养阳性标本灵敏度:更新版78%对比旧版50%(P=0.008)。
- 特异性:两版均为99%。
临床怎么用
- 更新版可提高低菌量、涂片阴性标本的MTBC检出,减少额外反射检测需求,简化高通量结核筛查实验室流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tuberculosis (TB) remains a major global health challenge, requiring rapid, reliable molecular tests to detect the Mycobacterium tuberculosis complex (MTBC) and resistance to the drugs that cause multidrug resistance, i.e., rifampicin and isoniazid. Although many moderate-complexity automated nucleic acid amplification tests use multiple targets to improve sensitivity, previous versions of FluoroType MTBDR (FTv2old; Bruker-Hain) relied on a single MTBC DNA target, often necessitating the use of an initial multilocus MTBC assay in the workflow to achieve comparable sensitivity. This prospective head-to-head study compared FTv2old with an updated version (FTv2new) that includes the multi-copy IS6110 insertion sequence to improve MTBC detection. Using 1,483 clinical specimens from pulmonary and extrapulmonary sources, with culture and whole-genome sequencing (WGS) as reference standards, FTv2new showed a significant 17-percentage-point increase in overall sensitivity, reaching 87% compared with 70% for FTv2old (P = 0.008). The improvement was particularly notable in microscopy-negative, culture-positive samples, where the sensitivity increased from 50% to 78% (P = 0.008). Specificity remained high and comparable between versions at 99%. Because the assay's resistance-conferring targets remained unchanged, the capability for resistance profiling did not improve significantly. These findings indicate that inclusion of the IS6110 target closes the performance gap of the FluoroType platform, eliminating the need for reflex testing and streamlining laboratory workflows for high-throughput tuberculosis screening.IMPORTANCETuberculosis remains a major global health threat, and rapid, accurate diagnosis is essential for disease control. This study evaluates an updated molecular assay for detecting the Mycobacterium tuberculosis complex (MTBC). Earlier versions of this assay relied on a single genetic target and were less sensitive than competing methods. The inclusion of a multi-copy target significantly improves MTBC detection, particularly in specimens with low bacterial loads that are frequently microscopy-negative. This improvement is clinically relevant, enabling faster, more reliable diagnosis while eliminating the need for additional, time-consuming reflex testing, thereby streamlining laboratory workflows and supporting timely initiation of appropriate treatment, thereby supporting global efforts to eliminate TB.
引用
- Svensson E, Folkvardsen DB, Norman A, et al. Increased sensitivity of the updated FluoroType MTBDR V2 with addition of IS6110 analysis. J Clin Microbiol. 2026. PMID: 42334219. doi:10.1128/jcm.00268-26
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。